B-Cell Lymphomas: Key Trials From ASH 2020

December 5-8, 2020; Virtual
Download this summary slideset with highlights of key data in chronic lymphocytic leukemia and B-cell lymphomas from ASH 2020.
Format: Microsoft PowerPoint (.ppt)
File Size: 1.31 MB
Released: December 22, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
AstraZeneca

Related Content

Sagar Lonial, MD; Suzanne Lentzsch, MD, PhD; and Thomas G. Martin, MD discuss the use of BCMA-targeted agents in relapsed/refractory multiple myeloma in an on-demand webcast, from Clinical Care Options (CCO)

Sagar Lonial, MD
Program Director
Suzanne Lentzsch, MD, PhD Thomas G. Martin, MD
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: October 15, 2021 Expired: October 14, 2022

Patient-friendly resource on myelodysplastic syndromes from Clinical Care Options (CCO)

person default Sara Tinsley, PhD, ARNP, AOCN Released: October 15, 2021

Steven M. Horwitz, MD, shares his thoughts on current management of T-cell lymphomas using biomarkers and targeted therapies, from Clinical Care Options (CCO)

Steven M. Horwitz, MD Released: October 14, 2021

Download this short summary slideset on myelodysplastic syndromes to help diagnose and manage your patients, from Clinical Care Options (CCO).

Amy E. DeZern, MD, MHS Daniel Pollyea, MD, MS Amer Zeidan, MBBS Released: October 12, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue